Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | PKM | P14618 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 9/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 8/20 | 0.47 |
| ▸ | PTP4A3 | O75365 | 2/20 | 0.45 |
| ▸ | PTP4A2 | Q12974 | 2/20 | 0.45 |
| ▸ | PTP4A1 | Q93096 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27441080 | 0.88 | PTP4A1 (0.59) | KDM4EPKMEGFRALDH1A1SMN1; SMN2 | |
| SCHEMBL27441062 | 0.88 | PTP4A1 (0.59) | KDM4EPKMEGFRALDH1A1SMN1; SMN2 | |
| SCHEMBL27441069 | 0.88 | PTP4A1 (0.59) | KDM4EPKMEGFRALDH1A1SMN1; SMN2 | |
| SCHEMBL27441085 | 0.88 | PTP4A1 (0.59) | KDM4EPKMEGFRALDH1A1SMN1; SMN2 | |
| SCHEMBL27441088 | 0.85 | EGFR (0.57) | KDM4EPKMCYP1A2EGFRALDH1A1 | |
| SCHEMBL27441075 | 0.85 | EGFR (0.57) | KDM4EPKMCYP1A2EGFRALDH1A1 | |
| SCHEMBL27441083 | 0.85 | EGFR (0.57) | KDM4EPKMCYP1A2EGFRALDH1A1 | |
| SCHEMBL27441064 | 0.85 | EGFR (0.57) | KDM4EPKMCYP1A2EGFRALDH1A1 | |
| SCHEMBL22259980 | 0.84 | KDM4E (0.75) | KDM4EPKMCYP1A2EGFRALDH1A1 | |
| SCHEMBL27440577 | 0.84 | ALDH1A1 (0.52) | KDM4EPKMEGFRALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | KDM4E 2780/4885PKM 1506/4885CYP1A2 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.